aap Implantate AG
aap Implantate AG / Silver coating technology: Further progress on the way to the targeted market approval – global orthopaedic companies remain keenly interested
DGAP-News: aap Implantate AG / Key word(s): Regulatory Admission/Study aap Implantate AG (“aap”) continued the talks with different global orthopaedic companies in mid-March at the American Academy of Orthopaedic Surgeons (“AAOS”) in Las Vegas, USA briefing them especially on the current status regarding its antibacterial silver coating technology. These companies remain keenly interested in aap’s innovative silver coating technology. With a view to the targeted market approval of its silver coating technology aap submitted at the end of 2018 the application to conduct a human clinical study to the Federal Institute for Drugs and Medical Devices (“BfArM”) and is now involved in an intensive exchange with the Federal Institute. At the same time, the applications have been submitted to ethics commissions in the meanwhile with a first positive feedback. The next step is the submission of a corresponding application to the US authority. On the basis of the interaction with the BfArM and the reaffirmation of interest by global orthopaedic companies aap will be further intensifying talks and negotiations with them. Concretely, the Company is discussing in addition to joint product development and approval projects also distribution partnerships as well as licensing deals up to the sale of the technology for specific application areas. —————————————————————————————————————————————
28.03.2019 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG. |
Language: | English |
Company: | aap Implantate AG |
Lorenzweg 5 | |
12099 Berlin | |
Germany | |
Phone: | +49 (0) 30 75 01 90 |
Fax: | +49 (0) 30 75 01 91 11 |
E-mail: | info@aap.de |
Internet: | www.aap.de |
ISIN: | DE0005066609 |
WKN: | 506660 |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 793149 |
End of News | DGAP News Service |